Abstract: The invention pertains to an assay that is capable of detecting a mutant polynucleotide in a plurality of polynucleotides. In one embodiment, the assay of the invention is capable of detecting one copy of a mutant polynucleotide in about 50,000 to about 100,000 copies of polynucleotides. The assay of the invention can be used to identify a mutant viral quasispecies or a mutant mRNA encoding an oncogenic protein from a tumor sample. The assay of the invention involves producing the single stranded complements of each of a plurality of polynucleotides containing the target sequence, wherein each of the single stranded complements contain a unique tag sequence and amplifying the single stranded complements by PCR using several sets of primers designed to introduce the sequences appropriate for a paired-end sequencing analysis of the amplified polynucleotides. The invention also pertains to kits for carrying out the assays of the invention.
Type:
Grant
Filed:
December 23, 2016
Date of Patent:
October 27, 2020
Assignee:
UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Inventors:
Gary P. Wang, Chak Kar (Eric) Li, Lin Liu
Abstract: Methods, compositions, and systems are provided for characterization of modified nucleic acids. In certain preferred embodiments, single molecule sequencing methods are provided for identification of modified nucleotides within nucleic acid sequences. Modifications detectable by the methods provided herein include chemically modified bases, enzymatically modified bases, abasic sites, non-natural bases, secondary structures, and agents bound to a template nucleic acid.
Type:
Grant
Filed:
September 28, 2016
Date of Patent:
October 6, 2020
Assignee:
Pacific Biosciences of California, Inc.
Inventors:
Benjamin Flusberg, Stephen Turner, Jon Sorenson, Kevin Travers, Cheryl Heiner
Abstract: The present invention provides methods for detecting the presence or absence of a nucleic acid variant in a target region. These methods include amplifying the target region with a forward primer and a reverse primer in the presence of a selector blocker. The selector blocker includes a sequence complementary to the target region in the absence of the nucleic acid variant. The methods further include detecting amplification of the target region where amplification of the target region indicates the presence of the nucleic acid variant in the target region. The nucleic acid variant can include deletions, mutations or insertions.
Abstract: The present invention is directed to methods and compositions for adding tails of specific lengths to a substrate polynucleotide. The invention also contemplates methods and compositions for immobilization of tailed substrates to a solid support. The disclosure contemplates that the attenuator molecule is any biomolecule that associates with a tail sequence added to a substrate polynucleotide and controls the addition of a tail sequence to the 3? end of the substrate polynucleotide. The sequence that is added to the substrate polynucleotide is referred to herein as a tail sequence, or simply a tail, and the process of adding a nucleotide to a substrate polynucleotide is referred to herein as tailing.
Abstract: The technology described herein is directed to methods of determining oligonucleotide sequences, e.g. by enriching target sequences prior to sequencing the sequences.
Type:
Grant
Filed:
May 21, 2018
Date of Patent:
July 21, 2020
Assignee:
THE GENERAL HOSPITAL CORPORATION
Inventors:
Anthony John Iafrate, Long Phi Le, Zongli Zheng
Abstract: Methods of amplification, purification and detection of nucleic acid sequences especially RNA are described. One aspect of the method involves the hybridisation and subsequent ligation of a nucleic acid structure to the nucleic acid sequence desired to be manipulated. The methods require that the nucleic acid structure comprises a double stranded region and a single stranded region. The single stranded region is complementary to the RNA sequence of interest. The double stranded region may also contain additional functionalities which are then used subsequently in the method.
Type:
Grant
Filed:
April 30, 2018
Date of Patent:
July 7, 2020
Assignee:
GE HEALTHCARE BIO-SCIENCES CORP.
Inventors:
John R. Nelson, R. Scott Duthie, Rohini Dhulipala, Gregory A. Grossman, Anuradha Sekher
Abstract: Aspects of the technology disclosed herein relate to methods of preparing and analyzing nucleic acids. In some embodiments, methods for preparing nucleic acids for sequence analysis (e.g., using next-generation sequencing) are provided herein.
Type:
Grant
Filed:
September 15, 2017
Date of Patent:
July 7, 2020
Assignee:
ArcherDX, Inc.
Inventors:
Joshua Stahl, Jason Myers, Brady Culver, Brian Kudlow
Abstract: Aspects of the technology disclosed herein relate to methods of preparing and analyzing nucleic acids, e.g, cfDNA. In some embodiments, methods for preparing nucleic acids for sequence analysis (e.g., using next-generation sequencing) are provided herein.
Type:
Grant
Filed:
September 15, 2017
Date of Patent:
June 16, 2020
Assignee:
ArcherDX, Inc.
Inventors:
Joshua Stahl, Jason Myers, Brady Culver, Brian Kudlow
Abstract: Methods and reagents suitable for conducing polymerase chain reaction are described. In particular, a nucleic acid amplification design strategy and thermal cycling profile to enable efficient amplification of multiple nucleic acid targets along with improved sensitivity is disclosed. The present disclosure also describes methods and devices for increasing the melting temperature (Tm) of a primer.
Abstract: A method of using an exchange-induced remnant magnetization (EXIRM) technique for label free detection of short strands of nucleotides and cancer biomarkers, such as DNA and microRNA strands, DNA/RNA-binding biomarkers, and cancer-specific antigens, with high sensitivity, high specificity, and broad dynamic range. The method may provide a label-free approach aimed to facilitate high reliability, and to require a minimum amount of biochemical reagents.
Type:
Grant
Filed:
October 25, 2018
Date of Patent:
May 5, 2020
Assignee:
University of Houston System
Inventors:
Shoujun Xu, Li Yao, Yuhong Wang, Qiongzheng Hu, Haopeng Yang
Abstract: Methods and compositions for enriching a population of particles containing an analyte are disclosed. In one embodiment, enrichment beads are used that are larger in size than the beads used for amplification. A separation device is employed that can retain larger beads with bound amplified beads. The technique finds many uses, including enriching for beads with clonally amplified template, which can be used in a variety of assays, including nucleic acid sequencing.
Type:
Grant
Filed:
November 1, 2018
Date of Patent:
April 21, 2020
Assignee:
QIAGEN SCIENCES, LLC
Inventors:
Jerzy Olejnik, Steven Gordon, Martina Werner
Abstract: The present invention relates to a primer for PCR obtained by, directly or through inosine as a linker, linking a complementary nucleotide sequence or a complementary nucleotide sequence including a mis-matched nucleotide sequence to the 5?-terminal of a forward or reverse primer; and to a PCR method including a step of mixing a nucleic acid template in a PCR composition including the primer and then performing PCR on the mixture. The primer for PCR of the present invention includes a complementary nucleotide sequence or a mis-matched nucleotide sequence in a complementary nucleotide sequence, which is linked to the 5?-terminal thereof directly or via a linker, thereby lowering the sensitivity increase due to the increase in amplification products and reducing non-specifically occurring reactions in PCR.
Type:
Grant
Filed:
January 7, 2016
Date of Patent:
April 14, 2020
Assignee:
SD BIOSENSOR, Inc.
Inventors:
Yoo-Deok Won, Hae-joon Park, Sunyoung Lee
Abstract: The invention relates to methods for the detection of a specific sequence of RNA in a cell or tissue sample. The invention also relates to methods to enzymatically manipulate the RNA in a crude cell lysate in a number of applications.
Abstract: The present invention provides novel compositions, methods and apparatus for DNA sequencing that can be performed, e.g., in a two-electrode chamber. The present invention also provides a method for sequencing a nucleic acid comprising immobilizing a plurality of complexes comprising a target nucleic acid, a primer nucleic acid, and a polymerase onto a surface, contacting the surface with a plurality of charged particles comprising a nucleotide phosphate by applying an electric field, reversing the electric field to transport unbound charged particles away from the surface, and detecting the incorporation of a nucleotide phosphate into a single molecule of the primer nucleic acid.
Abstract: Provided herein are methods and compositions for the capture of nucleic acids, for example by using a nucleic acid-guided nuclease-based system.
Type:
Grant
Filed:
August 18, 2016
Date of Patent:
January 21, 2020
Assignee:
Arc Bio, LLC
Inventors:
Stephane B. Gourguechon, Eric Harness, David Sinclair, Meredith L. Carpenter
Abstract: A kit useful for determining the phage susceptibility of one or more strains of Lactococcus lactis is described. The disclosure also describes methods for formulation of mixed defined starter cultures using strains from different phage sensitivity groups.
Type:
Grant
Filed:
March 13, 2014
Date of Patent:
January 21, 2020
Assignee:
DSM IP ASSETS B.V.
Inventors:
Douwe Van Sinderen, Finn Vogensen, Jennifer Mahony, Witold Kot, Stuart Ainsworth
Abstract: The present invention provides methods, kits, and oligonucleotides for detecting and analyzing the nucleotide sequence of a reverse transcriptase (RT) region of the polymerase (Pol) gene of Hepatitis B Virus (HBV). In certain embodiments, a target RT region is amplified and subjected to DNA sequencing. The sequence obtained is compared to one or more DNA sequences characteristic of an HBV genotype or serotype, and/or one or more DNA sequences characteristic of an HBV mutation that confers resistance to a drug or vaccine, to determine the HBV genotype or serotype of the amplified product and/or the presence or absence of one or more DNA sequences characteristic of an HBV mutation that confers resistance to a drug or vaccine.
Type:
Grant
Filed:
April 30, 2015
Date of Patent:
January 7, 2020
Assignee:
ABBOTT MOLECULAR INC.
Inventors:
Gregor W. Leckie, Reuben J. Ofsaiof, Roy M. Vijesurier, Hong Wang
Abstract: One complementary DNA (cDNA) encodes a collagenase enzyme of Lucilia sericata that includes an identified sequence. Optionally, the cDNA is applied to wound healing.
Abstract: A method for determining the sequence of nucleotide bases in a polynucleotide analyte is provided. It is characterised by the steps of (1) generating a stream of single nucleotide bases from the analyte; (2) producing captured molecules by reacting each single nucleotide base with a capture system; (3) amplifying at least part of the captured molecule to produce a plurality of amplicons characteristic of the single nucleotide base; (4) labelling the amplicons with a corresponding probe having a characteristic detectable element and (5) detecting a property characteristic of the detectable element.
Type:
Grant
Filed:
April 9, 2014
Date of Patent:
November 19, 2019
Assignees:
BASE4 INNOVATION LTD, UNITED KINGDOM RESEARCH AND INNOVATION
Inventors:
Cameron Alexander Frayling, Barnaby Balmforth, Bruno Flavio Nogueira de Sousa Soares, Thomas Henry Isaac, Boris Breiner, Alessandra Natale, Michele Amasio, Paul Dear
Abstract: Methods modifying conventional SIP so that isotopic incorporation into the genomes of individual microbial taxa can be quantified are described. Further, methods to quantify the baseline densities of the DNA of individual microbial taxa without exposure to isotope tracers and then to quantify the change in DNA density of each taxon caused by isotope incorporation are described. The distribution of DNA of each taxon along a density gradient reflects the influence of isotope incorporation only, without reflecting the guanine-plus-cytosine content.
Type:
Grant
Filed:
June 30, 2017
Date of Patent:
November 12, 2019
Assignee:
ARIZONA BOARD OF REGENTS ON BEHALF OF NORTHERN ARIZONA UNIVERSITY
Inventors:
Bruce Hungate, Egbert Schwartz, Rebecca Mau, Jane Marks